Zomedica Corp. Files Definitive Additional Proxy Materials
Ticker: ZOMDF · Form: DEFA14A · Filed: May 30, 2025 · CIK: 1684144
| Field | Detail |
|---|---|
| Company | Zomedica Corp. (ZOMDF) |
| Form Type | DEFA14A |
| Filed Date | May 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-filing, corporate-governance, shareholder-communication
TL;DR
Zomedica dropped more proxy docs, check your inbox.
AI Summary
Zomedica Corp. filed a Definitive Additional Materials proxy statement on May 30, 2025, related to its Schedule 14A filing. The company, previously known as Zomedica Pharmaceuticals Corp. until September 8, 2016, is headquartered in Ann Arbor, Michigan. This filing is a follow-up to materials sent out on May 24, 2025.
Why It Matters
This filing indicates Zomedica is providing supplementary information to shareholders regarding proxy matters, which could influence voting decisions on corporate governance or strategic initiatives.
Risk Assessment
Risk Level: low — This is a routine proxy filing, not indicating any immediate financial distress or significant corporate event.
Key Players & Entities
- Zomedica Corp. (company) — Registrant
- Zomedica Pharmaceuticals Corp. (company) — Former company name
- Ann Arbor, Michigan (location) — Company headquarters
- May 30, 2025 (date) — Filing date
- May 24, 2025 (date) — Date materials were sent
FAQ
What is the purpose of a DEFA14A filing?
A DEFA14A filing, or Definitive Additional Materials, is used by a company to provide supplementary information to shareholders after the initial proxy statement has been filed, often in response to new developments or to clarify existing information.
When was Zomedica Corp. previously known by another name?
Zomedica Corp. was formerly known as Zomedica Pharmaceuticals Corp. until September 8, 2016.
Where is Zomedica Corp. located?
Zomedica Corp. is located in Ann Arbor, Michigan, with its business and mailing address at 100 Phoenix Drive, Suite 125.
What is the filing date of this specific document?
The filing date for this DEFA14A filing is May 30, 2025.
What type of SEC filing is this?
This is a DEFA14A filing, specifically marked as 'Definitive Additional Materials' under Schedule 14A.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on May 30, 2025 regarding Zomedica Corp. (ZOMDF).